Andrew T.

Andrew T. has extensive work experience in the field of antibody engineering and virology. Andrew is currently working at Cell Signaling Technology (CST) as a Principal Scientist, where they lead antibody engineering projects. Prior to CST, Andrew worked at Scripps Research, where they held various roles including Senior Staff Scientist and Staff Scientist. During their time at Scripps Research, they made significant contributions to the development of therapeutics against activation checkpoints and the investigation of genetic barriers to viral escape variants. Andrew also led a team to study host-virus interactions and contributed to a project on glycosylation pathways. Before joining Scripps Research, Andrew worked as a Postdoctoral Research Fellow at the University of York. Overall, Andrew T. has a strong background in research and has made important contributions to the field of antibody engineering and virology.

Andrew T. completed their education from 2005 to 2008 at Newcastle University, where they obtained a Bachelor of Science (BSc) degree in Biochemistry. Andrew then pursued further studies at the University of York from 2008 to 2013, earning a PhD in Chemistry. In 2021, they obtained certification as a Member of the Royal Society of Chemistry from the Royal Society of Chemistry.